Currently out of the existing stock ratings of Michael Ryskin, 45 are a HOLD (37.5%), 62 are a BUY (51.67%), 13 are a SELL (10.83%).

Michael Ryskin

Work Performance Price Targets & Ratings Chart

Analyst Michael Ryskin, currently employed at BAML, carries an average stock price target met ratio of 70.31% that have a potential upside of 17.98% achieved within 162 days.

Michael Ryskin’s has documented 239 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on A, Agilent Technologies at 27-Aug-2026.

Wall Street Analyst Michael Ryskin

Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for SDGR (SCHRODINGER) at 5/14/2020. The price target of $60 was fulfilled within 5 days with a profit of $6 (11.11%) receiving and performance score of 22.22.

Average potential price target upside

ABSI Absci Corp ALGN Align Technology ELAN Elanco Animal Health IDXX IDEXX Laboratories OMIC Singular Genomics Systems SDC SmileDirectClub SDGR Schrodinger RXRX Recursion Pharmaceuticals EXAI Exscientia Ltd ADR ZTS Zoetis MRVI Maravai Lifesciences Holdings  ILMN Illumina AVTR Avantor CERT Certara DHR Danaher TEM Tempus AI, Common Stock BRKR Bruker CRL Charles River Laboratories ICLR ICON PLC MTD Mettler-Toledo International PAHC Phibro Animal Health A Agilent Technologies GH Guardant Health LH Laboratory of America Holdings RVTY Revvity TMO Thermo Fisher Scientific WST West Pharmaceutical Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Jan-2025

$11

$1.26 (12.94%)

$11

Buy Since 28-May-2026

$16

$6.26 (64.27%)

$13

20 days ago
(08-Sep-2026)

1/4 (25%)

$7.09 (79.57%)

27

Buy Since 08-May-2026

$17

$7.26 (74.54%)

$11

2 months 26 days ago
(02-Jul-2026)

1/2 (50%)

$5.38 (46.30%)

52

Buy Since 16-May-2023

$16

$6.26 (64.27%)

3 months 3 days ago
(25-Jun-2026)

12/13 (92.31%)

$5.79 (56.71%)

453

Buy Since 02-Oct-2024

$15

$5.26 (54.00%)

$10

3 months 13 days ago
(15-Jun-2026)

3/4 (75%)

$7.73 (106.33%)

553

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Ryskin most bullish on?

Potential upside of $12.75 has been obtained for GH (GUARDANT HEALTH)

Which stock is Michael Ryskin most reserved on?

Potential downside of -$22.33 has been obtained for ICLR (ICON PLC)

What Year was the first public recommendation made by Michael Ryskin?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?